tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Enliven Therapeutics (ELVN) Similar Stocks

Compare
287 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Enliven Therapeutics
$21.80
$1.05B
37.11%
4 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$37.46
$3.42B
1.66%
13 Buy
1 Hold
0 Sell
Strong Buy
Bicycle Therapeutics
$11.66
$828.19M
-49.74%
5 Buy
2 Hold
0 Sell
Moderate Buy
Immunovant
$21.27
$3.47B
-41.73%
8 Buy
1 Hold
0 Sell
Strong Buy
Context Therapeutics
$0.81
$59.25M
-30.43%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ELVN
Enliven Therapeutics
21.80
5.27
31.88%
CRNX
Crinetics Pharmaceuticals
37.46
0.61
1.66%
BCYC
Bicycle Therapeutics
11.66
-12.98
-52.68%
IMVT
Immunovant
21.27
-15.73
-42.51%
CNTX
Context Therapeutics
0.81
-0.35
-30.17%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis